Drug
BEBT-908 clinical trials
Also written CUDC-908 and BEBT-908.
A product of Ifupinostat; its studies count on that page too.
Keep track of what changes. Save the BEBT-908 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
4 studies that test it; most in 2016 (1)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2020 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 2 · Other 2
BeBetter Med Inc (2) · Ruijin Hospital (1) · The First Affiliated Hospital of Soochow University (1)
Related medicines
As reviewed, each with the page that says it.
- A brand or code of Ifupinostat
- One of Histone Deacetylase Inhibitors source
- One of Protein Kinase Inhibitors source
Studies
Open first, then newest update. How each study uses BEBT-908 is read from its arms, and is right about nine times in ten.
Testing it · 4
- BEBT-908 in MEF2D-Rearranged Relapsed/Refractory or MRD-Positive B-Cell Precursor Acute Lymphoblastic LeukemiaRecruitingPhase 1The First Affiliated Hospital of Soochow UniversityNCT07854652Written as Ifupinostat Hydrochloride
- BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia PatientsNot yet recruitingPhase 2Ruijin HospitalNCT07301138Written as BEBT-908
- Study of BEBT-908 in the Relapsed or Refractory Diffuse Large B-cell Lymphoma SubjectsCompletedPhase 2BeBetter Med IncNCT06074107Written as BEBT-908 for injection
- Study of BEBT-908 in Subjects With Advanced Hematological TumorsCompletedPhase 1BeBetter Med IncNCT06082596Written as BEBT-908 for injection
Given in every arm · 1 — BEBT-908 is usual care beside what is tested
Codes
What other systems call BEBT-908 · ClinicalTrials.gg INT000799
- MeSH (NLM) C000623235BEBT-908One source ClinicalTrials.gov
- UNII (FDA) SM27EVR8ZUBEBT-908One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000623235 | BEBT-908 | One source ClinicalTrials.gov |
| UNII (FDA) | SM27EVR8ZU | BEBT-908 | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.